Fulcrum Therapeutics Inc (FULC) earnings · $427.0M cap
These earnings events as JSON? API free 100/dayFulcrum Therapeutics Inc (FULC) is a biotechnology company listed on US.
This FULC earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported FULC revenue for 2025-12-31 was $0. Net income was -$74.9M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. FULC currently screens at market cap $427.0M.
When the next FULC 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 100.0% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full FULC research stays on the stock page; the tape stays on the quote page.
FULC earnings FAQ
What is FULC's latest net income?
Latest cached Fulcrum Therapeutics Inc (FULC) net income was -$74.9M. Statements: https://lician.com/financials/fulc
What is FULC's latest diluted EPS?
Latest cached Fulcrum Therapeutics Inc (FULC) diluted EPS for Dec 31, 2025 was -$1181.91.
What period does the latest FULC earnings print cover?
The latest cached Fulcrum Therapeutics Inc (FULC) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
Where are FULC earnings listed?
Cached earnings facts for Fulcrum Therapeutics Inc (FULC) are listed at https://lician.com/earnings/fulc. Statements: https://lician.com/financials/fulc
Not investment advice.